Format
Items per page
Sort by

Send to:

Choose Destination

Links from

Items: 1 to 20 of 90

1.

Adenovirus-specific IgG maturation as a surrogate marker in acute exacerbations of COPD.

Boeck L, Gencay M, Roth M, Hirsch HH, Christ-Crain M, Mueller B, Tamm M, Stolz D.

Chest. 2014 Aug;146(2):339-47. doi: 10.1378/chest.13-2307.

PMID:
24722914
2.

Reduced rhinovirus-specific antibodies are associated with acute exacerbations of chronic obstructive pulmonary disease requiring hospitalisation.

Yerkovich ST, Hales BJ, Carroll ML, Burel JG, Towers MA, Smith DJ, Thomas WR, Upham JW.

BMC Pulm Med. 2012 Jul 31;12:37. doi: 10.1186/1471-2466-12-37.

3.

Hospitalization with acute exacerbation of chronic obstructive pulmonary disease and associated health resource utilization: a population-based Danish cohort study.

Johannesdottir SA, Christiansen CF, Johansen MB, Olsen M, Xu X, Parker JM, Molfino NA, Lash TL, Fryzek JP.

J Med Econ. 2013 Jul;16(7):897-906. doi: 10.3111/13696998.2013.800525. Epub 2013 May 23.

PMID:
23621504
4.

Predictors of exacerbations in chronic obstructive pulmonary disease--results from the Bergen COPD cohort study.

Husebø GR, Bakke PS, Aanerud M, Hardie JA, Ueland T, Grønseth R, Persson LJ, Aukrust P, Eagan TM.

PLoS One. 2014 Oct 3;9(10):e109721. doi: 10.1371/journal.pone.0109721. eCollection 2014.

5.

Copeptin, C-reactive protein, and procalcitonin as prognostic biomarkers in acute exacerbation of COPD.

Stolz D, Christ-Crain M, Morgenthaler NG, Leuppi J, Miedinger D, Bingisser R, Müller C, Struck J, Müller B, Tamm M.

Chest. 2007 Apr;131(4):1058-67.

PMID:
17426210
6.

[A study on viral infections in patients with chronic obstructive pulmonary disease].

Xue Q, Liu S, Yuan Y, Guo L, Guan J, Wang B.

Zhonghua Jie He He Hu Xi Za Zhi. 2002 Jun;25(6):341-3. Chinese.

PMID:
12126557
7.

Serological evidence of Mycoplasma pneumoniae infection in acute exacerbation of COPD.

Lieberman D, Lieberman D, Ben-Yaakov M, Shmarkov O, Gelfer Y, Varshavsky R, Ohana B, Lazarovich Z, Boldur I.

Diagn Microbiol Infect Dis. 2002 Sep;44(1):1-6.

PMID:
12376023
8.

Use of B-type natriuretic peptide in the risk stratification of acute exacerbations of COPD.

Stolz D, Breidthardt T, Christ-Crain M, Bingisser R, Miedinger D, Leuppi J, Mueller B, Tamm M, Mueller C.

Chest. 2008 May;133(5):1088-94. doi: 10.1378/chest.07-1959. Epub 2008 Mar 13.

PMID:
18339792
9.
11.

[Causes of chronic obstructive pulmonary disease-related death and influencing factors of survival time].

Chang C, Yao WZ, Fang TS.

Zhonghua Yi Xue Za Zhi. 2011 Mar 29;91(12):824-7. Chinese.

PMID:
21600162
12.

A Retrospective Longitudinal Within-Subject Risk Interval Analysis of Immunoglobulin Treatment for Recurrent Acute Exacerbation of Chronic Obstructive Pulmonary Disease.

Cowan J, Gaudet L, Mulpuru S, Corrales-Medina V, Hawken S, Cameron C, Aaron SD, Cameron DW.

PLoS One. 2015 Nov 11;10(11):e0142205. doi: 10.1371/journal.pone.0142205. eCollection 2015.

13.

Anemia is a mortality predictor in hospitalized patients for COPD exacerbation.

Martinez-Rivera C, Portillo K, Muñoz-Ferrer A, Martínez-Ortiz ML, Molins E, Serra P, Ruiz-Manzano J, Morera J.

COPD. 2012 Jun;9(3):243-50. doi: 10.3109/15412555.2011.647131. Epub 2012 Feb 23.

PMID:
22360381
14.

[Comprehension and recognition of acute exacerbation among chronic obstructive pulmonary disease patients].

Jiang M, Ma JF.

Zhonghua Liu Xing Bing Xue Za Zhi. 2013 Oct;34(10):1030-4. Chinese.

PMID:
24378002
15.

Acute exacerbation of COPD is associated with fourfold elevation of cardiac troponin T.

Søyseth V, Bhatnagar R, Holmedahl NH, Neukamm A, Høiseth AD, Hagve TA, Einvik G, Omland T.

Heart. 2013 Jan;99(2):122-6. doi: 10.1136/heartjnl-2012-302685. Epub 2012 Sep 28.

PMID:
23024006
16.

Serological evidence of Mycoplasma pneumoniae infection in patients with acute exacerbation of COPD: analysis of 100 hospitalizations.

Papaetis GS, Anastasakou E, Tselou T, Sotiriou A, Rarra VC, Roussou P, Karakatsani A, Orphanidou D.

Adv Med Sci. 2010;55(2):235-41. doi: 10.2478/v10039-010-0031-6.

PMID:
20934967
17.

Acute and latent adenovirus in COPD.

McManus TE, Marley AM, Baxter N, Christie SN, Elborn JS, Heaney LG, Coyle PV, Kidney JC.

Respir Med. 2007 Oct;101(10):2084-90. Epub 2007 Jul 13.

18.

Vitamin D levels and risk of acute exacerbations of chronic obstructive pulmonary disease: a prospective cohort study.

Kunisaki KM, Niewoehner DE, Connett JE; COPD Clinical Research Network.

Am J Respir Crit Care Med. 2012 Feb 1;185(3):286-90. doi: 10.1164/rccm.201109-1644OC. Epub 2011 Nov 10.

19.

Short- and medium-term prognosis in patients hospitalized for COPD exacerbation: the CODEX index.

Almagro P, Soriano JB, Cabrera FJ, Boixeda R, Alonso-Ortiz MB, Barreiro B, Diez-Manglano J, Murio C, Heredia JL; Working Group on COPD, Spanish Society of Internal Medicine.

Chest. 2014 May;145(5):972-80.

PMID:
24077342
20.

Recovery of humoral immunity is critical for successful antiviral therapy in disseminated mouse adenovirus type 1 infection.

Lenaerts L, Kelchtermans H, Geboes L, Matthys P, Verbeken E, De Clercq E, Naesens L.

Antimicrob Agents Chemother. 2008 Apr;52(4):1462-71. doi: 10.1128/AAC.01311-07. Epub 2008 Feb 11.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk